Hot Features
Premium
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Cerevel Therapeutics Holdings Inc | CERE | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 42.75 | 06:35:43 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 42.75 |
| Trades | Shares Traded | Average Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 19.59 - 43.5898 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| - | 0 | US$ 42.75 | USD |
Cerevel Therapeutics (CERE) Options Flow Summary
Cerevel Therapeutics Holdings Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 1.83B | 181.58M | - | 0 | -432.84M | -2.38 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Cerevel Therapeutics News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CERE Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 42.10 | 42.845 | 41.80 | 42.20 | 820,958 | 0.65 | 1.54% |
| 1 Month | 42.30 | 42.845 | 41.185 | 42.05 | 1,109,898 | 0.45 | 1.06% |
| 3 Months | 41.70 | 43.5898 | 40.66 | 42.00 | 1,422,574 | 1.05 | 2.52% |
| 6 Months | 23.10 | 43.5898 | 22.27 | 39.86 | 2,017,808 | 19.65 | 85.06% |
| 1 Year | 29.14 | 43.5898 | 19.59 | 36.20 | 1,365,477 | 13.61 | 46.71% |
| 3 Years | 14.64 | 46.1608 | 12.01 | 32.09 | 966,739 | 28.11 | 192.01% |
| 5 Years | 10.45 | 46.1608 | 9.00 | 31.24 | 871,517 | 32.30 | 309.09% |
Cerevel Therapeutics Description
| Cerevel Therapeutics Holdings Inc is dedicated to unraveling the mysteries of the brain to treat neuroscience diseases. The company is tackling neuroscience diseases with a differentiated approach that combines expertise in neurocircuitry with a focus on receptor selectivity. It has a diversified pipeline comprising five clinical-stage investigational therapies and several preclinical compounds with the potential to treat a range of neuroscience diseases, including schizophrenia, epilepsy, Parkinson's disease and substance use disorder. Cerevel Therapeutics is advancing its current research and development programs while exploring new modalities through internal research efforts, external collaborations or potential acquisitions. |
